Last October, a 42-year-old project manager named Daniel in Austin told me something I've heard dozens of times now: "I wasn't expecting to feel the sleep thing so fast." He'd started a no-DAC CJC-1295 + ipamorelin protocol at 100 mcg and 200 mcg respectively, injecting subcutaneously before bed. By day nine, he said he was waking up at 5:45 a.m. without an alarm, feeling genuinely rested for the first time in years. His IGF-1 went from 142 ng/mL at baseline to 198 ng/mL at six weeks. Not dramatic. Not life-altering on paper. But the subjective shift, particularly in sleep and gym recovery, was enough to keep him on protocol for the full twelve weeks.
Daniel's experience is common. CJC-1295 with ipamorelin is the single most prescribed compounded peptide combination for endogenous growth hormone support, and it has been for years. Two peptides, two different pituitary receptors, one syringe. The original CJC-1295 molecule was characterized by Teichman SL et al. in 2006; ipamorelin's pharmacology was published by Raun K et al. in 1998. Neither peptide is FDA-approved. Both are dispensed as compounded research peptides by licensed pharmacies under individual prescriptions. And the reason they get paired together is straightforward biochemistry, not marketing.
Two Receptors, One Amplified Pulse
CJC-1295 binds the GHRH receptor. Ipamorelin binds the ghrelin receptor (GHSR-1a). Those are genuinely separate targets with distinct intracellular signaling cascades. When you hit both at the same time, the resulting GH pulse is synergistic, not just additive. Published research on GHRH + GHRP combinations confirms this: the combined output exceeds the sum of the parts.
Here's the thing that actually matters for tolerability: both peptides are selective. Ipamorelin doesn't meaningfully raise cortisol or prolactin (unlike older GHRPs such as GHRP-6). CJC-1295 stays in its lane on the GHRH receptor. So when you stack them, you inherit both clean profiles. No hormonal crosstalk. No cortisol spikes. That selectivity is a big part of why this particular combination became the default rather than, say, GHRP-2 + Sermorelin.
Think of it like a sound system: one speaker handles bass, another handles treble. Neither one interferes with the other's range, and together you get something neither could produce alone.
DAC vs. No-DAC: Pick Your Format
There are two versions of CJC-1295 floating around, and the distinction matters more than most online forums suggest.
No-DAC (also called Mod GRF 1-29) has a short half-life. You inject it daily, usually in the same syringe as ipamorelin. This creates a pulsatile GH pattern, which is closer to how your pituitary naturally operates. The same-syringe convenience is hard to beat. Draw ipamorelin first, then CJC-1295 no-DAC into the same insulin syringe, inject subcutaneously, done. Total volume is usually 0.2 to 0.3 mL.
DAC CJC-1295 has a drug affinity complex that extends its half-life to roughly a week. You inject it once or twice weekly, while still taking ipamorelin daily. The result is a sustained GHRH baseline punctuated by daily ipamorelin pulses. Some clinicians prefer this for patients who want fewer injections on the CJC side, but the sustained signaling bothers others philosophically. It's a different hormonal texture.
One of the most common mistakes I see: someone buys the DAC version and injects it daily like the no-DAC. Wrong half-life model. You'll overshoot and get more water retention than you bargained for.
Standard Protocols
No-DAC stack (most common starting point):
Get provider-reviewed GLP-1 therapy
Side effects are manageable with the right support. A licensed provider can adjust your dose when you need it.
Start Free Assessment →- CJC-1295 no-DAC: 100 to 200 mcg per injection
- Ipamorelin: 200 to 300 mcg per injection
- Same syringe, subcutaneous, rotated injection sites
- Timing: pre-bed is non-negotiable. Some add a post-workout or fasted morning dose.
- Frequency: 1 to 3 times daily
- Cycle: 8 to 12 weeks on, 4 weeks off
DAC stack:
- CJC-1295 with DAC: 1 to 2 mg total weekly, split into 1 to 2 doses (e.g., Monday and Thursday)
- Ipamorelin: 200 to 300 mcg daily, pre-bed
- Same cycle length: 8 to 12 weeks on, 4 weeks off
Reconstitution is standard: 5 mg peptide vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration. Use bacteriostatic water, not sterile water. The benzyl alcohol preservative in bac water prevents microbial growth across the vial's multi-use lifespan. Sterile water is single-use and goes bad the moment you puncture the stopper.
What the Timeline Actually Looks Like
I'll be honest: the body composition changes take patience. Sleep improvements come first (weeks 1 to 2 for most people), and they're the most consistently reported benefit. Recovery between training sessions tends to follow in weeks 2 to 4. The composition shifts, leaner midsection, slightly better muscle fullness, start showing up around weeks 4 to 8, and they're subtle. You're not going to look in the mirror at week three and see a different person.
The boring truth is that this stack works best for people who already train consistently and eat adequate protein. It's an optimization tool, not a rescue mission. If your sleep hygiene is wrecked, your diet is chaotic, and you're sedentary, these peptides will underperform spectacularly.
Mild headache in the first week or two is the most frequently reported side effect. Some water retention (more pronounced with DAC). Vivid dreams, which most people actually enjoy. Nausea at higher doses. Injection-site irritation is rare if your technique is decent.
Cortisol and prolactin stay put. That's the whole point of this combination.
Who This Fits (and Who It Doesn't)
Good candidates: adults 35 and older with declining natural GH output, active training routines, stable metabolic markers (insulin, thyroid, fasting glucose), and the discipline to stick with a protocol for 8 to 12 weeks.
Absolute no-go: active or recent malignancy. Any GH-axis tool is contraindicated when cancer is in the picture. Poorly controlled diabetes is another disqualifier. And if you're expecting this stack to replace the basics (sleep, training, nutrition), save your money.
Layering With Other Peptides
The CJC-1295 + ipamorelin foundation sometimes gets layered with non-GH peptides for specific goals:
- BPC-157 for tissue repair
- TB-500 for systemic recovery support
- GHK-Cu for skin, hair, and gene-expression modulation
These layered protocols need clinical oversight. Stacking four peptides because a Reddit thread said so is not a protocol; it's an experiment with one subject and no controls.
Mistakes That Keep Coming Up
A short list, because I keep seeing the same ones:
- Dosing after a fatty meal. Fat blunts the GH pulse. Inject fasted or at least 90 minutes post-meal.
- Running continuously past 12 weeks with no break. There's no human safety data supporting year-round use.
- Inconsistent dosing. Sporadic injections defeat the purpose of pulsatile signaling. Either commit to the protocol or don't start.
- Switching between DAC and no-DAC mid-cycle. Pick one format and stick with it.
- Reconstituting with sterile water instead of bacteriostatic water.
FAQ
Why is this particular stack so widely prescribed?
It pairs the cleanest GHRH analog with the cleanest GHRP, covering both pituitary pathways without redundancy or hormonal side effects. The same-syringe no-DAC format is also the simplest possible compounded peptide protocol, which helps with compliance.
Should a first-time user choose DAC or no-DAC?
No-DAC + ipamorelin in the same syringe is the standard starting point. DAC is convenient (fewer CJC injections), but the sustained signaling profile is something most clinicians reserve for patients with some experience on the no-DAC version first.
How long until I notice something?
Sleep changes: 1 to 4 weeks. Recovery: 2 to 6 weeks. Body composition: 4 to 12 weeks. Skin and connective tissue improvements take longer and often require multiple cycles.
Can I run this year-round?
Most clinicians prescribe 8 to 12 weeks on, 4 weeks off. Continuous dosing isn't backed by current human safety data, and receptor desensitization is a theoretical concern with chronic GHRH-R stimulation.
What bloodwork should I get?
Baseline: IGF-1, fasting glucose, HbA1c, lipid panel, TSH, free T4. Mid-cycle IGF-1 is the single most useful marker to gauge your response.
What if I don't respond well?
Finish the planned cycle, document what you observed, and reassess with your prescribing clinician. Dose adjustment, frequency changes, or swapping the CJC version often resolves underwhelming responses. Not everyone is a strong GH-axis responder, and that's worth knowing before investing in further cycles.
Is there a meaningful difference in results between DAC and no-DAC stacks?
The subjective reports overlap significantly. DAC users sometimes report more water retention and a "smoother" sustained feeling; no-DAC users tend to describe more distinct pulsatile effects, particularly around sleep. Neither version has demonstrated clear superiority in published data.
Related Reading
---
Disclaimer: CJC-1295 and ipamorelin are not FDA-approved. They are compounded research peptides dispensed by licensed pharmacies for individual patients under a valid prescription. This article is for educational purposes and does not constitute medical advice. Individual results vary. Always consult a licensed prescribing clinician before starting any compounded peptide protocol.
Citations: Teichman SL et al. 2006 (CJC-1295); Raun K et al. 1998 (ipamorelin).